Top Clinical Trials companies in India by Operating Cash Flow

This ranking features the top 2 Clinical Trials companies in India ranked by Operating Cash Flow, totaling a Operating Cash Flow of USD -6.54 M, for February 01, 2025.

India

Clinical Trials
Operating Cash Flow
#
Name
Operating Cash Flow
 Reported Date
Stock Price
Change
 Price (30 days) Country
1
VIMTALABS.NS

Vimta Labs Limited

1

VIMTALABS.NS
USD 7.30 M
March 31, 2024 USD 9.86 2.71%

India
2
SUVEN.NS

Suven Life Sciences Limited

2

SUVEN.NS
USD -13.84 M
March 31, 2024 USD 1.48 10.54%

India
Frequently Asked Questions
  • Which Clinical Trials company in India has the highest Operating Cash Flow ?

    The Clinical Trials company in India with the highest Operating Cash Flow is Vimta Labs Limited (NSE: VIMTALABS.NS) at USD 7.30 M.

  • Which Clinical Trials company in India has the lowest Operating Cash Flow ?

    The Clinical Trials company in India with the lowest Operating Cash Flow is Suven Life Sciences Limited (NSE: SUVEN.NS) at USD -13.84 M.

SV Wall Street